Palmitoylethanolamide (PEA, Powder)
- Product Code: 8804
amide (amide) of fatty acids within the body It has been shown to bind to receptors in the cell nucleus. which is a receptor that activates the peroxisome proliferator and acts to reduce pain and chronic inflammation
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
| Test Name | Specification |
|---|---|
| Appearance | Fine white crystal powder |
| Color | White to Off-white |
| Identification | Positive |
| Loss on Drying | 1.0% Max |
| Water | 1.0% Max |
| Residue on ignition | 0.1% Max |
| Purity (HPLC) | 99.0% Min |
| Lead (Pb) | 0.5 mg/kg Max |
| Total Arsenic (As) | 0.15 mg/kg Max |
| Cadmium | 2.5 mg/kg Max |
| Total Mercury (Hg) | 1.5 mg/kg Max |
| Residue solvent: Methanol | 0.3% Max |
| Residue solvent: Ethanol | 0.5% Max |
| Residue solvent: Ethyl acetate | 0.5% Max |
| Total Plate Count | 10000CFU/g Max |
Palmitoylethanolamide (PEA) amide (amide) of fatty acids within the body. It has been shown to bind to receptors in the cell nucleus. It is a receptor that activates the peroxisome proliferator and acts to reduce pain and chronic inflammation.
PEA has been shown in clinical trials to help reduce the severity of peripheral neuropathy such as diabetic neuropathy, chemotherapy-induced peripheral neuropathy, osteoarthritis pain, low back pain, and chemotherapy. Postoperative pain, toothache, neuropathic pain in stroke and sclerosis, chronic pelvic pain.
It is now used as an ingredient in dietary supplements. many countries
The Food and Drug Administration (FDA) of Thailand has not yet allowed its use in dietary supplements.
this item Sold for research purposes only, not for human use.
Be the first to review this product :-)
Recommend Lab-Service
| Lab Service | Price |
|---|
Palmitoylethanolamide (PEA, Powder)
amide (amide) of fatty acids within the body It has been shown to bind to receptors in the cell nucleus. which is a receptor that activates the peroxisome proliferator and acts to reduce pain and chronic inflammation
Palmitoylethanolamide (PEA) amide (amide) of fatty acids within the body. It has been shown to bind to receptors in the cell nucleus. It is a receptor that activates the peroxisome proliferator and acts to reduce pain and chronic inflammation.
PEA has been shown in clinical trials to help reduce the severity of peripheral neuropathy such as diabetic neuropathy, chemotherapy-induced peripheral neuropathy, osteoarthritis pain, low back pain, and chemotherapy. Postoperative pain, toothache, neuropathic pain in stroke and sclerosis, chronic pelvic pain.
It is now used as an ingredient in dietary supplements. many countries
The Food and Drug Administration (FDA) of Thailand has not yet allowed its use in dietary supplements.
this item Sold for research purposes only, not for human use.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :